Patent application number | Description | Published |
20100273786 | TETRAHYDRO-IMIDAZ0[1,5-A]PYRAZINE DERIVATIVES, PREPARATION PROCESS AND MEDICINAL USE THEREOF - Tetrahydro-imidazo[1,5-a]pyrazine derivatives of formula (I), their preparation methods, pharmaceutical compositions containing the derivatives and uses thereof as medicaments, especially as dipeptidyl peptidase IV inhibitors, wherein the substituents of formula (I) are defined as same as the description. | 10-28-2010 |
20110274192 | SYNCHRONIZATION METHOD AND DEVICE FOR REAL-TIME DISTRIBUTED SYSTEM - In order to solve the technical problem that in the current real-time distributed systems such as multi-antenna MIMO system, the implementation of synchronization between distributed modules by means of software is of a large time overhead, the invention proposes a synchronization method and device for the real-time distributed system, the distributed module determines if the present module is able to operate synchronously, at a synchronization start time that is unified with the other distributed modules; sets the present module's operate indication signal in a logic circuit, based on the determining result; and decides whether the present module is to operate synchronously, following a rule unified with the other distributed modules, based on the present module's operate indication signal along with the operate indication signals in the logic circuit set by the other modules. The invention implements real-time synchronization between distributed modules by means of hardware logic circuit with small operation time overhead, and preferably it only needs several-bit logic circuit and several cascaded logic gates, the structure is concise, efficient, and easy to implement and extend. | 11-10-2011 |
20120065209 | TETRAHYDRO-IMIDAZO[1,5-a]PYRAZINE DERIVATIVES SALTS, PREPARATION METHODS AND MEDICINAL USE THEREOF - Pharmaceutically acceptable salts of (R)-7-[3-amino-4-(2,4,5-trifluorophenyl)-butyryl]-3-trifluoromethyl-5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine-1-formic acid, their preparation methods, compositions containing the said pharmaceutical salts and their use as medicaments, especially as dipeptidyl peptidase IV (DPP-IV) inhibitors are disclosed. | 03-15-2012 |
20120220766 | TETRAHYDRO-IMIDAZO[1,5-alpha] PYRAZINE DERIVATIVES, PREPERATION PROCESS AND MEDICINAL USE THEREOF - Tetrahydro-imidazo[1,5-a]pyrazine derivatives of formula (I), their preparation methods, pharmaceutical compositions containing the derivatives and uses thereof as medicaments, especially as dipeptidyl peptidase IV inhibitors, wherein the substituents of formula (I) are defined as same as the description. | 08-30-2012 |
20130060596 | Easy Process Modeling Platform - The present disclosure describes methods, systems, and computer program products for generic process modeling. One method includes identifying a business process for execution, the business process defined by one or more process steps, identifying a process routing table associated with the identified business process, at least a portion of the process routing table including one or more entries defining a set of business process rules for the identified business process, identifying a particular entry in the process routing table associated with a current state of the identified business process; and performing at least one action defined by the identified particular entry in the process routing table. In some instances, at least one entry in the process routing table is associated with one of a plurality of process patterns, with each process pattern comprising a reusable, predefined operation. | 03-07-2013 |
20130065814 | INDUCTIVE PRODUCTION OF PLURIPOTENT STEM CELLS USING SYNTHETIC TRANSCRIPTION FACTORS - The present invention relates to use of synthetic factors in reprogramming somatic cells to become induced pluripotent stem cells and other cell lineages. Specifically, the present application relates to fusion proteins containing proteins encoded by cell totipotency-related genes and transcription regulatory domains, their coding sequences, expression vectors, and compositions. The present application also relates to methods for reprogramming somatic cells to become induced pluripotent stem cells and other cell lineages, and cells containing the fusion proteins or the coding sequences. | 03-14-2013 |
20140083451 | METHOD FOR IN SITU CLEANING OF MOCVD REACTION CHAMBER - The present invention provides a method for in situ cleaning of an MOCVD reaction chamber. The method includes: introducing a first cleaning gas into the reaction chamber, and converting the first cleaning gas into a first plasma inside the reaction chamber, and maintaining the pressure inside the reaction chamber in a first predetermined pressure range for a first time period, to remove a carbonaceous organic substance inside the reaction chamber; introducing a second cleaning gas into the reaction chamber, and converting the second cleaning gas into second plasma inside the reaction chamber, and maintaining the pressure inside the reaction chamber in a second predetermined pressure range for a second time period, to remove metal and its compound inside the reaction chamber. | 03-27-2014 |
20140083452 | METHOD FOR IN SITU CLEANING OF MOCVD REACTION CHAMBER - The present invention provides a method for in situ cleaning of an MOCVD reaction chamber. The method includes: maintaining the internal pressure of the MOCVD reaction chamber in a predetermined pressure range, and keeping a plasma inside the MOCVD reaction chamber for a predetermined time period to completely remove deposits inside the MOCVD reaction chamber. The method for in situ cleaning of an MOCVD reaction chamber according to the embodiments of the present invention may remove relatively stable organic ligands or related polymers, resulting in a good cleaning effect for the removal of the deposits on the surfaces with a relatively low temperature inside the MOCVD reaction chamber. | 03-27-2014 |
20140083453 | METHOD FOR IN SITU CLEANING OF MOCVD REACTION CHAMBER - A method for in situ cleaning of a Metal-Organic Chemical Vapor Deposition reaction chamber is provided in embodiments of the present invention. The method includes: introducing a first cleaning gas into the reaction chamber, converting the first cleaning gas into first plasma inside the reaction chamber to completely remove a carbonaceous organic substance inside the reaction chamber, wherein the first cleaning gas includes a first oxygen-containing gas; and introducing a second cleaning gas into the reaction chamber, and converting the second cleaning gas into second plasma inside the reaction chamber to completely remove a metallic oxide inside the reaction chamber, wherein the second cleaning gas includes a first halogen-containing gas. | 03-27-2014 |